How the AmplideX® PCR/CE CFTR Kit Streamlines the Detection of Diverse Pathogenic Variants in Under Five Hours

Does testing for more CFTR mutations yield greater coverage?  Do your panels reflect your testing population’s diversity? Many CFTR panels were principally designed to detect mutations that are common in Caucasians. Recent studies, however, have shown that many CFTR carriers may be missed in ethnically-diverse populations, including the US demographic. This workshop will evaluate the quality versus quantity of variants in CFTR mutation testing, relate this concept to the design, performance, and simplicity of the AmplideX® PCR/CE CFTR Kit*, and translate the benefits of this kit to the streamlined, scalable, and rapid detection of mutations across different populations.

Please fill out the information below to access the video.

By checking this box, I agree to receive relevant marketing communications regarding products, industry news, literature, and events from Asuragen. I understand that I can change my preferences at any time. I further understand that any data provided to Asuragen will be stored, used, and deleted consistent with Asuragen’s Privacy Notice.

Back To
Top

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close